Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3c9fc3cb0028234aedb8df651f9d2e4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-70 |
filingDate |
2006-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5ad63c51428eed81c52ffafbfdcea5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4518edb471a7a61cb2a6b2988a3dd6fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d2dbe3bb09be7e537c795418eb4b1ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9041820bf788c05a472f5880e193e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfa41c004e80f793c19efa49c4b8ea7 |
publicationDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7837997-B2 |
titleOfInvention |
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
abstract |
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots are provided wherein fibrinolytic or anticoagulant drugs are biocompatibly coupled to red blood cell carriers. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10940209-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666638-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946079-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471155-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9878048-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9814780-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10953101-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9518087-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9850296-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9901645-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9901646-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10919963-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9517257-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10046056-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11246943-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253579-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800838-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10392437-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265415-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821157-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265416-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654188-B2 |
priorityDate |
1998-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |